Advertisement

Topics

Jiangsu Hengrui Medicine Co., Ltd. Company Profile

07:58 EDT 21st April 2018 | BioPortfolio

Jiangsu Hengrui Medicine Co., Ltd., established in 1970, is a leading biopharmaceutical company based in China with annual net sales of over $1.6 billion in 2016. Hengrui is devoted to empowering healthier lives through research, and currently has 3 programs under China NDA as well as 21 new molecular entities in clinical development in China, U.S., and Australia, across oncology, anesthesiology & pain management, immunology & inflammation, and cardiovascular & metabolic diseases.


News Articles [741 Associated News Articles listed on BioPortfolio]

TG Therapeutics signs BTK inhibitor deal with Jiangsu Hengrui

TG Therapeutics Inc. licensed exclusive global rights (excluding Asia but including Japan) to two of Jiangsu Hengrui Medicine Co. Ltd.’s Bruton’s tyrosine kinase (BTK) inhibitors. The deal puts TG...

Jiangsu Hengrui Out-Licenses Novel Dermatology Drug for $233 Million

Jiangsu Hengrui Medicine out-licensed ex-China rights for a novel JAK inhibitor to Arcutis Pharma, a California dermatology company, in a deal worth up to $233 million, plus royalties. Arcutis will ha...

TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancies

US IND Filing Expected in the First Half of 2018 Hengrui is Eligible to Receive Collaboration and Licensing Payments of Approximately $350MM, in Addition to Royalties on Future Sales NEW YORK an...

Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercialization Partnership for Novel Immune-Mediated Dermatology Therapy Using SHR0302

Arcutis obtains exclusive rights to conduct clinical development and pursue a U.S., EU, and Japan license for the commercialization of a topical JAK inhibitor for der...

Jiangsu Hengrui Medicine Co Ltd 600276 Financial and Strategic SWOT Analysis Review [Report Updated: 25102017] Prices from USD $125

Jiangsu Hengrui Medicine Co Ltd 600276 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been co...

Jiangsu Hengrui Medicine Co Ltd 600276 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15022018] Prices from USD $250

SummaryJiangsu Hengrui Medicine Co Ltd Jiangsu Hengrui is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of innovative pharmaceutical products. Its...

Jiangsu Hengrui Medicine Co Ltd 600276 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryJiangsu Hengrui Medicine Co Ltd Jiangsu Hengrui is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of innovative pharmaceutical products. Its...

Global and Europe Oxaliplatin Market Status and Future Forecast 20132023 [Report Updated: 10012018] Prices from USD $3500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

PubMed Articles [1006 Associated PubMed Articles listed on BioPortfolio]

Population data and phylogenetic structure of Han population from Jiangsu province of China on GlobalFiler STR loci.

Forensic statistical parameters based on allelic frequencies of commonly used short tandem repeats were estimated for the Han population of Jiangsu province from P.R. China. The 6-dye GlobalFiler™ P...

Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Jiangsu Province, China, is highly developed economically and culturally, and has a high prevalence of lung cancer. We aimed to evaluate the diagnostic procedures, genetic aberration analysis status, ...

Genetic diversity of Jiangsu native chicken breeds assessed with the mitochondrial DNA D-loop region.

1. The objective of this study was to determine the origin and evolution of chickens from 5 native breeds that are traditionally raised in Jiangsu Province. 2. The sequence of the mitochondrial D-loop...

Research on distribution of native places of some doctors from the Qin-Han Dynasties to the Republican Period.

The native places of the famous Chinese medicine doctors listed in the Volume on History of Medicine and Medical Literature of the Great Dictionary of Traditional Chinese Medicine were analyzed and co...

Ten years of Experience and Progress of Electronic Immunization Registry System in Jiangsu Province, China.

The use of electronic immunization registry system (EIRs) can improve the vaccine coverage monitoring significantly. The EIRs in Jiangsu Province, China was set up since 2006. In this paper, we summar...

Clinical Trials [1206 Associated Clinical Trials listed on BioPortfolio]

A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure

Hepatocellular carcinoma (HCC) is one of the lethal human cancers worldwide and its incidence matches mortality, reflecting the poor prognosis of this disease. The surgical resection rate ...

Safety, Blood Levels and Effects of GW642444

GW642444 (the study medicine) is a new experimental medicine for treating asthma and chronic obstructive pulmonary disease (COPD). People with asthma and COPD suffer from breathlessness b...

Pilot Study of Vedic Medicine for Type 2 Diabetes

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

This study looks at a new study medicine for weight control in people with overweight or obesity. The aim of this study is to see if the study medicine is safe for people to take. The stud...

Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer

Although patients of colorectal cancer use Traditional Chinese Medicine (TCM) herbal therapy extensively in China, no strong evidence exists to demonstrate the safety and survival outcomes...

Companies [1037 Associated Companies listed on BioPortfolio]

Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd., established in 1970, is a leading biopharmaceutical company based in China with annual net sales of over $1.6 billion in 2016. Hengrui is devot...

China National Chemical Construction Jiangsu Company

China National Chemical Construction Jiangsu Company was established in January, 1992. It has independent corporate status and has the right to do foreign trade directly. It has one pesticide manufact...

Jiangsu Aolunda High-Tech. Industry Co., Ltd.

JIANGSU AOLUNDA HIGH-TECH., INDUSTRY CO.,LTD adjoinsthe Asian-Pacific banking centre of Shanghai, located in the Changjiang Delta of economic prosperity, it lies in the southeast of Jiangsu and border...

JIANGSU GUOTAI INTERNATIONAL GROUP

Jiangsu Guotai International Group is a complex group which covers international trade of textile, light industry, hardware, chemicals, minmetals, etc. Its department 3, specialized in hardware tradin...

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

More Information about "Jiangsu Hengrui Medicine Co., Ltd." on BioPortfolio

We have published hundreds of Jiangsu Hengrui Medicine Co., Ltd. news stories on BioPortfolio along with dozens of Jiangsu Hengrui Medicine Co., Ltd. Clinical Trials and PubMed Articles about Jiangsu Hengrui Medicine Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jiangsu Hengrui Medicine Co., Ltd. Companies in our database. You can also find out about relevant Jiangsu Hengrui Medicine Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record